Shanghai Chicmax Cosmetic Co., Ltd. (HKG:2145)
Hong Kong · Delayed Price · Currency is HKD 65.30
+0.85 (1.32%)
At close: Feb 13, 2026
Shanghai Chicmax Cosmetic Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 7,398 | 6,793 | 4,191 | 2,675 | 3,619 | 3,382 | |
Revenue Growth (YoY) | 21.16% | 62.08% | 56.64% | -26.07% | 7.02% | 17.65% |
Cost of Revenue | 1,905 | 1,722 | 1,198 | 1,009 | 1,325 | 1,253 |
Gross Profit | 5,493 | 5,071 | 2,993 | 1,666 | 2,294 | 2,129 |
Selling, General & Admin | 4,549 | 4,190 | 2,450 | 1,481 | 1,834 | 1,800 |
Research & Development | 204.68 | 179.87 | 125.81 | 110.28 | 104.75 | 77.38 |
Other Operating Expenses | 8.39 | 10.26 | 7.29 | 4.95 | 5.79 | 4.01 |
Operating Expenses | 4,768 | 4,387 | 2,568 | 1,608 | 1,951 | 1,881 |
Operating Income | 725.6 | 683.49 | 424.95 | 57.72 | 342.94 | 247.93 |
Interest Expense | -5.72 | -6.07 | -16.23 | -20.47 | -20.93 | -40.5 |
Interest & Investment Income | 6.13 | 6.13 | 9.37 | 0.81 | 0.46 | 2.13 |
Earnings From Equity Investments | 2.18 | -1.61 | -6.01 | -1.23 | -0.15 | 1.86 |
Currency Exchange Gain (Loss) | 1.62 | 1.62 | 12.8 | -4.55 | -5.15 | -5.11 |
Other Non Operating Income (Expenses) | 341.65 | 224.12 | 118.21 | 121.83 | 88.64 | 72.39 |
EBT Excluding Unusual Items | 1,071 | 907.67 | 543.09 | 154.11 | 405.8 | 278.71 |
Gain (Loss) on Sale of Investments | 52.14 | 19.3 | 16.12 | 0.08 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.04 | 2.33 | 0.92 |
Pretax Income | 1,124 | 926.97 | 559.21 | 154.23 | 408.12 | 279.63 |
Income Tax Expense | 177.14 | 123.67 | 97.55 | 17.15 | 69.35 | 76.44 |
Earnings From Continuing Operations | 946.47 | 803.3 | 461.66 | 137.08 | 338.77 | 203.18 |
Minority Interest in Earnings | -42.31 | -22.09 | -0.56 | 10.02 | 0.12 | 0.28 |
Net Income | 904.16 | 781.21 | 461.1 | 147.1 | 338.89 | 203.46 |
Net Income to Common | 904.16 | 781.21 | 461.1 | 147.1 | 338.89 | 203.46 |
Net Income Growth | 18.76% | 69.42% | 213.45% | -56.59% | 66.56% | 225.16% |
Shares Outstanding (Basic) | 398 | 398 | 398 | 361 | 360 | 360 |
Shares Outstanding (Diluted) | 398 | 398 | 398 | 361 | 360 | 360 |
Shares Change (YoY) | 0.02% | 0.02% | 10.22% | 0.28% | - | - |
EPS (Basic) | 2.27 | 1.96 | 1.16 | 0.41 | 0.94 | 0.57 |
EPS (Diluted) | 2.27 | 1.96 | 1.16 | 0.41 | 0.94 | 0.57 |
EPS Growth | 18.73% | 69.39% | 184.39% | -56.71% | 66.56% | 225.16% |
Free Cash Flow | 473.06 | 313.58 | 658.33 | -17.77 | 272.07 | 126.17 |
Free Cash Flow Per Share | 1.19 | 0.79 | 1.65 | -0.05 | 0.76 | 0.35 |
Dividend Per Share | 1.250 | 1.500 | 0.950 | 0.250 | 0.560 | - |
Dividend Growth | -16.67% | 57.89% | 280.00% | -55.36% | - | - |
Gross Margin | 74.25% | 74.65% | 71.41% | 62.28% | 63.38% | 62.95% |
Operating Margin | 9.81% | 10.06% | 10.14% | 2.16% | 9.48% | 7.33% |
Profit Margin | 12.22% | 11.50% | 11.00% | 5.50% | 9.36% | 6.02% |
Free Cash Flow Margin | 6.39% | 4.62% | 15.71% | -0.66% | 7.52% | 3.73% |
EBITDA | 800.47 | 748.47 | 493.54 | 123.36 | 404.7 | 296.51 |
EBITDA Margin | 10.82% | 11.02% | 11.78% | 4.61% | 11.18% | 8.77% |
D&A For EBITDA | 74.87 | 64.98 | 68.59 | 65.64 | 61.76 | 48.58 |
EBIT | 725.6 | 683.49 | 424.95 | 57.72 | 342.94 | 247.93 |
EBIT Margin | 9.81% | 10.06% | 10.14% | 2.16% | 9.48% | 7.33% |
Effective Tax Rate | 15.77% | 13.34% | 17.44% | 11.12% | 16.99% | 27.34% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.